 Erin Hanlon
Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 8 | 2021 | 310 | 2.910 |
Why?
| | Glycerides | 4 | 2020 | 22 | 2.830 |
Why?
| | Arachidonic Acids | 4 | 2020 | 49 | 2.820 |
Why?
| | Endocannabinoids | 4 | 2020 | 49 | 2.720 |
Why?
| | Sleep | 10 | 2021 | 435 | 1.990 |
Why?
| | Sleep Deprivation | 6 | 2016 | 144 | 1.460 |
Why?
| | Eating | 6 | 2016 | 174 | 1.120 |
Why?
| | Obesity | 7 | 2020 | 966 | 1.070 |
Why?
| | Conditioning, Operant | 4 | 2010 | 67 | 1.040 |
Why?
| | Reward | 6 | 2016 | 156 | 1.030 |
Why?
| | Motivation | 3 | 2013 | 259 | 0.710 |
Why?
| | Nucleus Accumbens | 2 | 2010 | 114 | 0.640 |
Why?
| | Hyperphagia | 1 | 2016 | 35 | 0.630 |
Why?
| | Amphetamine | 2 | 2010 | 105 | 0.450 |
Why?
| | Food | 1 | 2010 | 85 | 0.410 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2009 | 68 | 0.390 |
Why?
| | Motor Skills | 1 | 2009 | 77 | 0.380 |
Why?
| | Leptin | 3 | 2020 | 113 | 0.370 |
Why?
| | Diabetes Mellitus | 2 | 2015 | 757 | 0.370 |
Why?
| | Sleep Disorders, Circadian Rhythm | 2 | 2020 | 14 | 0.360 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 230 | 0.360 |
Why?
| | Hydrocortisone | 3 | 2020 | 302 | 0.350 |
Why?
| | Synapses | 1 | 2011 | 332 | 0.350 |
Why?
| | Young Adult | 7 | 2021 | 5968 | 0.350 |
Why?
| | Central Nervous System Stimulants | 1 | 2010 | 219 | 0.340 |
Why?
| | Nerve Tissue Proteins | 2 | 2013 | 529 | 0.330 |
Why?
| | Cross-Over Studies | 2 | 2019 | 414 | 0.330 |
Why?
| | Motor Cortex | 1 | 2009 | 219 | 0.330 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 237 | 0.320 |
Why?
| | Psychomotor Performance | 1 | 2009 | 510 | 0.300 |
Why?
| | Body Weight | 2 | 2013 | 503 | 0.290 |
Why?
| | Muscimol | 1 | 2003 | 17 | 0.270 |
Why?
| | GABA Agonists | 1 | 2003 | 17 | 0.270 |
Why?
| | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2003 | 23 | 0.270 |
Why?
| | Wakefulness | 2 | 2016 | 132 | 0.260 |
Why?
| | Circadian Clocks | 2 | 2021 | 49 | 0.250 |
Why?
| | Male | 13 | 2021 | 41881 | 0.250 |
Why?
| | Rats | 6 | 2013 | 4351 | 0.240 |
Why?
| | Appetite Regulation | 2 | 2016 | 9 | 0.240 |
Why?
| | Adolescent | 5 | 2021 | 9135 | 0.230 |
Why?
| | Insulin Resistance | 2 | 2016 | 388 | 0.230 |
Why?
| | Zinc | 1 | 2021 | 95 | 0.230 |
Why?
| | Research Report | 1 | 2021 | 43 | 0.220 |
Why?
| | Rats, Sprague-Dawley | 4 | 2013 | 1370 | 0.220 |
Why?
| | Fasting | 3 | 2016 | 173 | 0.220 |
Why?
| | Brain | 1 | 2011 | 2159 | 0.220 |
Why?
| | Congresses as Topic | 1 | 2021 | 121 | 0.210 |
Why?
| | Adult | 7 | 2021 | 25984 | 0.210 |
Why?
| | Adie Syndrome | 1 | 2020 | 1 | 0.210 |
Why?
| | Gene Expression | 2 | 2019 | 1331 | 0.210 |
Why?
| | Palmitic Acids | 1 | 2019 | 15 | 0.210 |
Why?
| | Polyunsaturated Alkamides | 1 | 2019 | 11 | 0.210 |
Why?
| | Oleic Acids | 1 | 2019 | 26 | 0.210 |
Why?
| | Triiodothyronine | 1 | 2021 | 317 | 0.210 |
Why?
| | Ethanolamines | 1 | 2019 | 36 | 0.200 |
Why?
| | Amides | 1 | 2019 | 61 | 0.200 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 62 | 0.200 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 66 | 0.200 |
Why?
| | Analgesics, Opioid | 1 | 2003 | 373 | 0.190 |
Why?
| | Health Status Disparities | 1 | 2021 | 161 | 0.190 |
Why?
| | Humans | 17 | 2021 | 83350 | 0.190 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2019 | 286 | 0.180 |
Why?
| | Electroencephalography | 3 | 2011 | 713 | 0.170 |
Why?
| | Female | 8 | 2021 | 44762 | 0.170 |
Why?
| | Adipose Tissue | 1 | 2019 | 260 | 0.170 |
Why?
| | Animals | 11 | 2021 | 26976 | 0.160 |
Why?
| | Hunger | 1 | 2016 | 21 | 0.160 |
Why?
| | Ghrelin | 1 | 2015 | 22 | 0.150 |
Why?
| | Case-Control Studies | 1 | 2020 | 1825 | 0.150 |
Why?
| | Opioid Peptides | 1 | 2013 | 5 | 0.130 |
Why?
| | Bariatric Surgery | 1 | 2016 | 193 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2015 | 265 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1367 | 0.130 |
Why?
| | Neostriatum | 1 | 2013 | 39 | 0.130 |
Why?
| | Insulin | 3 | 2015 | 1169 | 0.130 |
Why?
| | Thinness | 1 | 2012 | 38 | 0.120 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2015 | 264 | 0.120 |
Why?
| | Reinforcement Schedule | 1 | 2010 | 19 | 0.110 |
Why?
| | Electrophysiological Phenomena | 1 | 2011 | 52 | 0.110 |
Why?
| | Up-Regulation | 1 | 2013 | 712 | 0.110 |
Why?
| | Behavior, Animal | 2 | 2011 | 380 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 1285 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2013 | 322 | 0.100 |
Why?
| | Rats, Long-Evans | 1 | 2009 | 44 | 0.100 |
Why?
| | Dominance, Cerebral | 1 | 2009 | 67 | 0.100 |
Why?
| | Electromyography | 1 | 2009 | 183 | 0.100 |
Why?
| | Frontal Lobe | 1 | 2009 | 128 | 0.090 |
Why?
| | Models, Biological | 1 | 2016 | 1798 | 0.090 |
Why?
| | Dopamine | 1 | 2010 | 293 | 0.090 |
Why?
| | Parietal Lobe | 1 | 2009 | 110 | 0.090 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2009 | 211 | 0.090 |
Why?
| | Cerebral Cortex | 1 | 2011 | 591 | 0.080 |
Why?
| | Appetitive Behavior | 1 | 2005 | 14 | 0.080 |
Why?
| | Brain Mapping | 1 | 2009 | 543 | 0.080 |
Why?
| | Disease Outbreaks | 1 | 2006 | 190 | 0.070 |
Why?
| | Dopamine Agents | 1 | 2003 | 33 | 0.070 |
Why?
| | Weight Loss | 1 | 2005 | 234 | 0.070 |
Why?
| | Health | 1 | 2021 | 31 | 0.060 |
Why?
| | Publications | 1 | 2021 | 21 | 0.060 |
Why?
| | Hormone Replacement Therapy | 1 | 2021 | 73 | 0.060 |
Why?
| | Disease | 1 | 2021 | 84 | 0.050 |
Why?
| | Reflex, Pupillary | 1 | 2020 | 7 | 0.050 |
Why?
| | Hypothyroidism | 1 | 2021 | 207 | 0.050 |
Why?
| | Mental Health | 1 | 2021 | 144 | 0.050 |
Why?
| | Melatonin | 1 | 2020 | 43 | 0.050 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 56 | 0.050 |
Why?
| | Reference Standards | 1 | 2019 | 146 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 991 | 0.050 |
Why?
| | Obesity, Morbid | 1 | 2019 | 211 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2021 | 1904 | 0.040 |
Why?
| | CLOCK Proteins | 1 | 2016 | 14 | 0.040 |
Why?
| | Middle Aged | 3 | 2021 | 25587 | 0.040 |
Why?
| | Endophenotypes | 1 | 2015 | 17 | 0.040 |
Why?
| | Food Deprivation | 1 | 2015 | 22 | 0.040 |
Why?
| | Blood Pressure | 1 | 2021 | 1197 | 0.040 |
Why?
| | Age of Onset | 1 | 2015 | 320 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 1433 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2020 | 2969 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 813 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 16 | 0.030 |
Why?
| | Neuropeptide Y | 1 | 2013 | 32 | 0.030 |
Why?
| | Neuropharmacology | 1 | 2013 | 2 | 0.030 |
Why?
| | Neuroanatomy | 1 | 2013 | 4 | 0.030 |
Why?
| | Homeostasis | 1 | 2015 | 397 | 0.030 |
Why?
| | Protein Precursors | 1 | 2013 | 148 | 0.030 |
Why?
| | Glucose | 1 | 2015 | 625 | 0.030 |
Why?
| | Neuroimaging | 1 | 2013 | 99 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2011 | 31 | 0.030 |
Why?
| | Neural Pathways | 1 | 2013 | 301 | 0.030 |
Why?
| | Risk Factors | 1 | 2021 | 5412 | 0.030 |
Why?
| | Causality | 1 | 2009 | 80 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3704 | 0.020 |
Why?
| | Models, Neurological | 1 | 2011 | 430 | 0.020 |
Why?
| | Action Potentials | 1 | 2011 | 635 | 0.020 |
Why?
| | Maternal Age | 1 | 2006 | 46 | 0.020 |
Why?
| | Endocrine System | 1 | 2006 | 15 | 0.020 |
Why?
| | Neoplasms | 1 | 2021 | 2691 | 0.020 |
Why?
| | Time Factors | 1 | 2015 | 5496 | 0.020 |
Why?
| | Temperature | 1 | 2006 | 420 | 0.020 |
Why?
| | Prospective Studies | 1 | 2012 | 4081 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2016 | 7895 | 0.020 |
Why?
| | Body Mass Index | 1 | 2006 | 784 | 0.020 |
Why?
| | Aged | 1 | 2020 | 18500 | 0.010 |
Why?
| | Smoking | 1 | 2006 | 568 | 0.010 |
Why?
| | Epigenesis, Genetic | 1 | 2006 | 434 | 0.010 |
Why?
| | Selection, Genetic | 1 | 2006 | 472 | 0.010 |
Why?
| | Prevalence | 1 | 2006 | 1263 | 0.010 |
Why?
| | Mice | 1 | 2015 | 11129 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 1915 | 0.010 |
Why?
|
|
Hanlon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|